NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

3M Beats Q4 Earnings But 2026 Guidance Disappoints Investors

3M surpasses Q4 2025 earnings estimates with $1.83 adjusted EPS as cost cuts and innovation drive growth, though 2026 guidance disappoints investors.

3M Beats Q4 Earnings But 2026 Guidance Disappoints Investors
Credit: Andrew Harrer/Bloomberg
Already have an account? Sign in.
01/20/2026 · 7:15 AM
MMM
/ Don’t stop at just one post.

Related↓

3M
10/21/2025 · 12:43 PM

3M Raises 2025 Profit Forecast on Strong Product Innovation and Cost Cuts

3M boosts annual profit outlook for second time in 2025, driven by new product launches, margin expansion, and CEO Bill Brown's cost-cutting strategy. Shares jump 6%.

/ Subscriber only
/ Read more

Feed↓

Adaptive Biotechnologies Plans to Split Its MRD and Immune Medicine Units
06/15/2026 · 4:45 PM

Adaptive Biotechnologies Plans to Split Its MRD and Immune Medicine Units

The company expects to decide the best path by year-end 2026.

/ Subscriber only
Stride Plunges After Losing Major Texas Virtual School Contract
06/15/2026 · 2:52 PM

Stride Plunges After Losing Major Texas Virtual School Contract

Stride shares plunged after Texas' Roscoe ISD decided not to renew its contract for Lone Star Online Academy, representing ~5% of 2025 enrollment. BMO highlights retention risks.

/ Subscriber only
H.C. Wainwright Says CNTX Stock Drop Is 'Overdone' After CTIM-76 Ovarian Cancer Data
06/15/2026 · 1:23 PM

H.C. Wainwright Says CNTX Stock Drop Is 'Overdone' After CTIM-76 Ovarian Cancer Data

Context Therapeutics reported positive Phase 1 data for CTIM-76 in heavily pretreated platinum-resistant ovarian cancer, showing a 29% response rate and good safety, but the stock fell due to small trial size.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe